Literature DB >> 5965323

Studies on adenosine deaminase. I. Purification and properties of ox heart adenosine deaminase.

M Rockwell, M H Maguire.   

Abstract

Mesh:

Substances:

Year:  1966        PMID: 5965323

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  8 in total

1.  Presynaptic inhibitory actions of 2-substituted adenosine derivatives on neurotransmission in rat vas deferens: effects of inhibitors of adenosine uptake and deamination.

Authors:  M J Muller; D M Paton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

2.  Partial purification and properties of the common inherited forms of adenosine deaminase from human erythrocytes.

Authors:  W R Osborne; N Spencer
Journal:  Biochem J       Date:  1973-05       Impact factor: 3.857

3.  Purification of adenosine deaminase from bovine lung and spleen.

Authors:  M Noonan; T G Brady
Journal:  Biochem J       Date:  1969-11       Impact factor: 3.857

4.  Hypothermia-induced supersensitivity to adenosine for responses mediated via A1-receptors but not A2-receptors.

Authors:  K J Broadley; S Broome; D M Paton
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

5.  The pivotal role of the mitochondrial amidoxime reducing component 2 in protecting human cells against apoptotic effects of the base analog N6-hydroxylaminopurine.

Authors:  Birte Plitzko; Antje Havemeyer; Thomas Kunze; Bernd Clement
Journal:  J Biol Chem       Date:  2015-02-23       Impact factor: 5.157

6.  Cardiovascular actions of substituted adenosine analogues.

Authors:  J A Angus; L B Cobbin; R Einstein; M H Maguire
Journal:  Br J Pharmacol       Date:  1971-04       Impact factor: 8.739

7.  Studies on the coronary dilator actions of some adenosine analogues.

Authors:  L B Cobbin; R Einstein; M H Maguire
Journal:  Br J Pharmacol       Date:  1974-01       Impact factor: 8.739

Review 8.  Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases.

Authors:  Barbara Kutryb-Zajac; Paulina Mierzejewska; Ewa M Slominska; Ryszard T Smolenski
Journal:  Molecules       Date:  2020-10-12       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.